Approval · Notice of Compliance 773 · 2002
BLES: Notice of Compliance 773
Issued February 4, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 773
- Date
- February 4, 2002
- Company
- Bles Biochemicals IncLondon, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Lung surfactant (bovine)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BLES | 02245464 | Marketed |
Medicinal ingredients
- PHOSPHOLIPID 27 MG per ML
- SURFACTANT-ASSOCIATED PROTEINS B & C 500 MCG per ML